��������Ƶ

Results support the theory that “backtracking” influences thousands of human genes.

The center, the first of its kind, seeks to produce more community-engaged research.

Dr. Alexandra Miller specializes in treating primary brain tumors.

Dr. Umamaheswar Duvvuri’s dedication to care combines basic and clinical research.

��

The trials, led by Dr. Scot Niglio, investigate using the immune checkpoint inhibitor pembrolizumab.

The discovery could lead to ways to improve the effectiveness of immunotherapies.

Dr. Helen Pass said breast cancer treatment no longer uses a “one-size-fits-all” approach.

The treatment promises to remove cancer cells with less risk of sexual dysfunction.

The study aims to reduce side effects without risking recurrence of the cancer.

Researchers swapped out a key organism’s genetic material for engineered replacements.